scientific Sessions

Drug Screening

Drug screening and designing are critical steps in drug discovery, where potential compounds are tested to identify their ability to interact with biological targets and treat diseases. Drug screening involves testing large libraries of compounds to identify "hits" that show activity against a target whereas Drug designing modifies the hits identified by changing their chemical structure for better efficacy, safety, and bioavailability. This phase ensures the lead compounds are potent and selective, making them strong candidates for further testing and development.

The Pharma R&D and Drug Discovery World Conference (PRDWC) offers a platform for industry leaders to explore the latest innovations in drug screening and designing and also includes discussions on technologies like high-throughput screening, computational drug design, and the integration of artificial intelligence in drug discovery, aimed at improving the efficiency and precision of identifying and designing effective therapeutic compounds.

Related Sessions

Pharmaceutical Research and Development
Drug Delivery Systems
Pharmaceutics
Pharmacology& Toxicology
Pharmacotherapeutics
Pharmaceutical Chemistry
Pharmacokinetics
Pharmacodynamics
Pharmacogenomics
Clinical Research
Clinical Trials
Personalized Medicine
Nanomedicine
Drug Discovery
Computer-Aided Drug Design
Advancements in Drug Discovery Technology
Challenges in Drug Discovery
Drug Screening
Pre-clinical Research
Pharmaceutical Product Development
Pharmaceutical Manufacturing
Quality Control & Quality Assurance
Regulatory & HTA Review
FDA Approvals
Product Management
Existing Drugs Enhancement
Bioavailability and Bioequivalence Studies
Advances in Pharmaceutical Sciences
Don't miss our future updates!

Get in Touch